While a recent spike in ADC approvals may not last forever, Antikor Biopharma’s Mahendra Deonarain asserts that antibody-drug conjugates are here to stay.

While bispecific antibodies target two specific entities, multispecific antibodies can target more than two. The use of these engineered antibodies offers the potential for enhanced therapeutic strategies by simultaneously addressing multiple aspects of a disease.

Advancements in cytokine understanding and synthetic immunology enable precise immune modulation, particularly in cancer treatment. However, challenges like short half-lives and side effects impact their wider clinical application.

Concise and insightful summaries of presentations delivered by prominent thought leaders at Biologics 2023

Discussing using a computational drug discovery platform for the development of multispecific antibody therapeutics.

How do we prepare for the next pandemic?

This whitepaper by Sino Biological discusses the different types of stem cells based on their origin and potential, as well as the factors that direct their differentiation toward specific lineages or cell types.

How were the COVID-19 vaccines developed so fast? And why were some countries left behind?

Professors Katalin Karikó and Drew Weissman have been awarded the 2023 Nobel Prize in Medicine for their contributions to the development of the COVID-19 mRNA vaccine.